Trial intelligence / Profile preview

Postoperative intravenous tranexamic acid in total knee arthroplasty

ChiCTR2000039368Phase 4Recruiting

Sponsor
The Second Affiliated Hospital of Anhui Medical University
Start
Oct 2020
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised trial of tranexamic acid in knee osteoarthritis (OA) (3 arms), sponsored by The Second Affiliated Hospital of Anhui Medical University. Primary endpoints: Hemoglobin (Hb), Hematocrit (Hct) and 1 more. Started Oct 2020; status: recruiting.

02

Drugs

tranexamic acid
03

Conditions

knee osteoarthritis (OA)

Beyond the preview

Go deeper on ChiCTR2000039368.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR2000039368.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call